Evidence map›Paper›PMID 37849657›Full record

ReviewBME frontiers2023

BME 2.0: Engineering the Future of Medicine.

Michael I Miller, Andrew O Brightman, Frederick H Epstein, K Jane Grande-Allen, Jordan J Green, Eileen Haase, Cato T Laurencin, Elizabeth Logsdon, Feilim Mac Gabhann, Brenda Ogle and 3 more

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BME frontiers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Michael I MillerDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Andrew O BrightmanWeldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
Frederick H EpsteinBiomedical Engineering, University of Virginia, Charlottesville, VA, USA.
K Jane Grande-AllenDepartment of Bioengineering, Rice University, Houston, TX, USA.
Jordan J GreenDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Eileen HaaseDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Cato T LaurencinDepartment of Biomolecular Engineering and Department of Orthopaedic Surgery, University of Connecticutt, Storrs, CT, USA.
Elizabeth LogsdonDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Feilim Mac GabhannDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Brenda OgleDepartment of Biomedical Engineering, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
Chun WangDepartment of Biomedical Engineering, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
George R WodickaWeldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
Rai WinslowDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.

Funding

Project 2 MeasurementU19AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI Mei Cheng Wang · 2014 to 2026
$51.5M
Neurodegenerative and Neurodevelopmental Subcortical Shape DiffeomorphometryR01EB020062 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI MILLER, MICHAEL I, MOSTOFSKY, STEWART H · 2016 to 2019
$2.8M
Tracing Spread of Pathology Within The HD Brain via Automated NeuroimagingR01NS102670 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MILLER, MICHAEL I, ROSS, CHRISTOPHER A · 2018 to 2021
$2.4M
NIA NIH HHS U19 AG033655NIBIB NIH HHS R01 EB020062NINDS NIH HHS R01 NS102670
6 · The paper itself

Abstract

If the 20th century was the age of mapping and controlling the external world, the 21st century is the biomedical age of mapping and controlling the biological internal world. The biomedical age is bringing new technological breakthroughs for sensing and controlling human biomolecules, cells, tissues, and organs, which underpin new frontiers in the biomedical discovery, data, biomanufacturing, and translational sciences. This article reviews what we believe will be the next wave of biomedical engineering (BME) education in support of the biomedical age, what we have termed BME 2.0. BME 2.0 was announced on October 12 2017 at BMES 49 (https://www.bme.jhu.edu/news-events/news/miller-opens-2017-bmes-annual-meeting-with-vision-for-new-bme-era/). We present several principles upon which we believe the BME 2.0 curriculum should be constructed, and from these principles, we describe what view as the foundations that form the next generations of curricula in support of the BME enterprise. The core principles of BME 2.0 education are (a) educate students bilingually, from day 1, in the languages of modern molecular biology and the analytical modeling of complex biological systems; (b) prepare every student to be a biomedical data scientist; (c) build a unique BME community for discovery and innovation via a vertically integrated and convergent learning environment spanning the university and hospital systems; (d) champion an educational culture of inclusive excellence; and (e) codify in the curriculum ongoing discoveries at the frontiers of the discipline, thus ensuring BME 2.0 as a launchpad for training the future leaders of the biotechnology marketplaces. We envision that the BME 2.0 education is the path for providing every student with the training to lead in this new era of engineering the future of medicine in the 21st century.

Identifiers

PMID37849657
PMCPMC10530648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.